<table><thead><th>TABLE 1-1, ECG Findings</th><th>Based on Location of Infarct</th></thead><tr><td>Location of Infarct</td><td>ECG Changes</td></tr><tr><td>Anterior</td><td>ST-segment elevation in V1—V4 (acute/active)</td></tr><tr><td></td><td>Q waves in leads V1-V4 (late change)</td></tr><tr><td rowspan="3">Posterior</td><td>Large R wave in V1 and V2</td></tr><tr><td></td><td>ST-segment depression in V1 and V2</td></tr><tr><td></td><td>Upright and prominent T waves in V1 and V2</td></tr><tr><td>Lateral</td><td>Q waves in leads I and aVL (late change)</td></tr><tr><td>(Inferior</td><td>Q waves in leads II, III, aVF (late change)</td></tr></table>
======================================
<table><thead><th></th><th>Same as general population</th></thead><tr><td>nirso</td><td>1.3</td></tr><tr><td></td><td>2.2</td></tr><tr><td>Wl</td><td>3.2</td></tr><tr><td>OLSWINI BRI</td><td>4.0</td></tr><tr><td>nan)</td><td>6.7</td></tr><tr><td>DI</td><td>9.8</td></tr><tr><td></td><td>9.6</td></tr><tr><td></td><td>12.5</td></tr><tr><td></td><td>15.2</td></tr></table>
======================================
<table><tr><td>eripheral rterial disease</td><td>Intermittent claudication, rest pain, decreased pulses, ischemic ulcers</td><td>Arteriogram</td><td>Intermittent claudication— conservative treatment</td></tr></table>
======================================
<table><thead><th>Disease</th><th>Clinical Features</th><th>Diagnosis</th><th>Treatment</th></thead><tr><td>Superficial thrombophlebitis</td><td>Local tenderness, erythema along the course of a superficial vein</td><td>Clinical diagnosis</td><td>Analgesics, monitor for spread or cellulitis</td></tr><tr><td>Chronic venous insufficiency</td><td>Aching of lower extremities, worse atendof day; relieved by elevation of legs and worsened by recumbency; edema, pigmentation, ulcers</td><td>Clinical diagnosis</td><td>Leg elevation, avoid long periods _ of standing, elastic stockings; if ulcers develop, Unna boots, wet- to-dry dressings</td></tr><tr><td>Deep venous thrombosis</td><td>Usually asymptomatic; calf pain may be present</td><td>Duplex, D-dimer</td><td>Anticoagulation</td></tr></table>
======================================
<table><thead><th>Shock</th><th>Cardiac Output</th><th>SVR</th><th>PCWP</th></thead><tr><td>Cardiogenic</td><td>J</td><td>t</td><td>t</td></tr><tr><td>Hypovolemic</td><td>J</td><td>t</td><td>J</td></tr><tr><td colspan="4">Distributive</td></tr><tr><td>Neurogenic</td><td>J</td><td>J</td><td>J</td></tr><tr><td>Septic</td><td>t</td><td>t)</td><td>J</td></tr><tr><td>Obstructive</td><td>J</td><td>t</td><td>Variable</td></tr></table>
======================================
<table><thead><th>Measurement</th><th>Obstructive</th><th>Restrictive</th></thead><tr><td>FEV,</td><td>Low</td><td>Normal or slightly low</td></tr><tr><td>FEV ,/FVC</td><td>Low</td><td>Normal or high</td></tr><tr><td>Peak expiratory flow rate</td><td>Low</td><td>Normal</td></tr><tr><td>Residual volume</td><td>High</td><td>Low, normal, or high</td></tr><tr><td>Total lung capacity</td><td>High</td><td>Low</td></tr><tr><td>Vital capacity</td><td>Low</td><td>Low</td></tr></table>
======================================
<table><thead><th>TABLE 2-3. Chronic Severity</th><th>Jreatment of Asthma Long-Term Control Medications</th></thead><tr><td>Mild intermittent (symptoms two or fewer times per wk)</td><td></td></tr><tr><td>Mild persistent (symptoms two or more times per wk but not every day)</td><td>Low-dose inhaled corticosteroid</td></tr><tr><td>Moderate persistent (daily symptoms; frequent exacerbations)</td><td>Daily inhaled corticosteroid (low dose) with long-acting inhaled B-agonist, or daily inhaled corticosteroid (medium dose). Alternatives include adding a leukotriene modifier or theophylline to the daily inhaled corticosteroid (low dose)</td></tr><tr><td>Severe persistent (continual symptoms, frequent exacerbations, limited physical activity)</td><td>Daily inhaled corticosteroid (medium or high dose) and long-acting inhaled B5- agonists. Omalizumab (anti-IgE) may be considered additionally. If poor control, systemic corticosteroids should be considered.</td></tr></table>
======================================
<table><thead><th>TABLE 2-5) Benign Versus Malignant</th><th>Solitary Pulmonary Nodules</th></thead><tr><td>Factors That Favor a Benign Diagnosis</td><td>Factors That Favor Malignancy</td></tr><tr><td>Age &lt;50 yrs</td><td>Age &gt;50 yrs</td></tr><tr><td>Nonsmoker</td><td>Smoker or previous smoker</td></tr><tr><td>Size of nodule &lt;2 cm</td><td>Size of nodule &gt;3 cm</td></tr><tr><td>No growth over 2-yr period</td><td>Steady growth over serial radiographs</td></tr><tr><td>Nodule circular and regular shaped</td><td>Nodule grossly irregular or with speculated margin</td></tr><tr><td>Central, laminated calcification</td><td>Stippled or eccentric pattern of calcification</td></tr></table>
======================================
<table><tr><td>Factor</td><td>Point:</td></tr><tr><td>Symptoms and signs of DVT</td><td>3.0</td></tr><tr><td>Alternative diagnosis less likely than PE</td><td>3.0</td></tr><tr><td>Heart rate &gt;100 beats/min</td><td>1.5</td></tr><tr><td>Immobilization (&gt;3 days) or surgery in previous 4 wks</td><td>1.5</td></tr></table>
======================================
<table><thead><th></th><th>e Normal PaCO,: 35-45 mm Hg</th><th>metabolic. When there is an inverse relationship, the primary disorder is respiratory.</th><th>can result in ischemia of the hand in patients with radial-dominant circulation.</th></thead><tr><td>Spirometry</td><td>¢ From maximum inspiration, the patient exhales as rapidly and forcibly as possible to maximum expiration. © Spirometer plots the change in lung volume against time (see lung volumes below).</td><td>¢ Helps to distinguish obstructive from restrictive lung disease. Useful in assessing degree of functional impairment as well as monitoring effectiveness of treatment (e.g., during asthma exacerbation). © May detect respiratory impairment in asymptomatic patients (e.g., smokers).</td><td>© Volumes are measured as percentages of predicted values based on age, height, and sex. Incorrect measurement or technique may lead to false positives.</td></tr><tr><td>Dlg</td><td>© The patient breathes ina small, specific amount of CO, and the amount transferred from alveolar air to pulmonary—capillary blood is measured. © CO is a diffusion-limited gas, so other variables are eliminated. ¢ Essentially measures the surface area of the alveolar—capillary membrane.</td><td>¢ Can often distinguish between asthma, emphysema, and COPD. ¢ Useful in monitoring various conditions, such as sarcoidosis and emphysema.</td><td>1. Causes for low DL¢g include: ¢ Emphysema © Sarcoidosis ¢ Interstitial fibrosis ¢ Pulmonary vascular disease © Also, lower with anemia due to reduced binding of CO to hemoglobin 2. Causes for high Doo: e Asthma (increased pulmonary— capillary blood volume) © Obesity Intracardiac left-to-right shunt Exercise © Pulmonary hemorrhage (alveolar RBCs bind with CO)</td></tr><tr><td>Ventilation— perfusion (V/Q) scan</td><td>© Compares the degree of ventilation to perfusion of the lungs; an exact match would correspond to a V/O ratio of 1. e Ahigh V/O ratio occurs when there is inadequate perfusion of an adequately ventilated lung. Thus, dead space is increased. ¢ The normal ratio of ventilation to perfusion is 0.8; so there is normally some degree of V/O mismatch, with some degree of shunting.</td><td>Diagnosis of PE</td><td>It is very rare to have a “normal” or “negative” V/O scan. When V/Q scans are ordered for evaluation of suspected PE, the result is usually “low,” “indeterminate,” or “high probability.”</td></tr><tr><td>Methacholine challenge</td><td>— Assesses degree of airway hyperreactivity</td><td>Patients in whom asthma or COPD is suspected</td><td>Sensitive in detecting airway hyperresponsiveness in mild asthma</td></tr></table>
======================================
<table><thead><th></th><th colspan="3">POINTS</th></thead><thead><th></th><th></th><th>Z</th><th>3</th></thead><tr><td>Ascites</td><td></td><td>Mild—moderate</td><td>Severe</td></tr><tr><td>Bilirubin(mg/dL)</td><td>&lt;2.0</td><td>2.0-3.0</td><td>&gt;3.0</td></tr><tr><td>Encephalopathy</td><td></td><td>Mild—moderate</td><td>Severe</td></tr><tr><td>INR ratio</td><td>Al</td><td>1.7-2.3</td><td>&gt;2.3</td></tr><tr><td>Albumin</td><td>&gt;3.5</td><td>2.8-3.5</td><td>&lt;2.8</td></tr></table>
======================================
<table><thead><th></th><th>Cholelithiasis</th><th>Choledocholithiasis</th></thead><tr><td>Abnormality</td><td>Stone in gallbladder</td><td>Stone in CBD</td></tr><tr><td>Clinical features</td><td>Asymptomatic; biliary colic</td><td>Asymptomatic, RUQ/epigastric pain, jaundice</td></tr><tr><td>Complications</td><td>Cholecystitis, choledocholithiasis, gallstone ileus, malignancy</td><td>Cholangitis, obstructive jaundice, acute pancreatitis, biliary cirrhosis</td></tr><tr><td>Diagnosis</td><td>RUQ ultrasound is highly sensitive</td><td>ERCP is the test of choice; RUQ ultrasound is not sensitive</td></tr><tr><td>Treatment</td><td>No treatment in most cases; elective cholecystectomy if biliary colic is severe or recurrent</td><td>Removal of stone via ERCP and sphincterotomy</td></tr></table>
======================================
<table><thead><th></th><th>Primary Biliary Cirrhosis</th><th>Primary Sclerosing Cholangitis</th></thead><tr><td>Pathology</td><td>Intrahepatic bile duct destruction</td><td>Intra- and extrahepatic bile duct thickening and lumenal narrowing</td></tr><tr><td>Demographics</td><td>Female &gt; male 9:1</td><td>Male &gt; female</td></tr><tr><td>Association with inflammatory bowel disease</td><td></td><td>Strong association with ulcerative colitis (UC) and also Crohn disease</td></tr><tr><td>Diagnosis</td><td>+ antimitochondrial antibodies (AMAs) in 90— 95% of patients. Liver biopsy to confirm diagnosis</td><td>ERCP will show bead-like dilations in intra- and extrahepatic bile ducts</td></tr><tr><td>Treatment</td><td>Ursodeoxycholic acid slows progression, liver transplantation</td><td>Liver transplantation</td></tr></table>
======================================
<table><thead><th>TABLE 3-4, Ranson Criteria</th><th></th><th></th></thead><thead><th>Admission Criteria (GALAW)</th><th>Initial 48-hr Criteria (C HOBBS)</th><th>Mortality</th></thead><tr><td>Glucose &gt;200 mg/dL</td><td>Calcium &lt;8 mg/dL Decrease in Hematocrit &gt;10%</td><td>&lt;3 criteria—1%</td></tr><tr><td>Age &gt;55 yrs</td><td>PaO, &lt;60 mm Hg</td><td>3-4 criteria—15%</td></tr><tr><td>LDH &gt;350</td><td>BUN increase &gt;5 mg/dL</td><td>5-6 criteria—40%</td></tr><tr><td>AST &gt;250</td><td>Base deficit &gt;4 mg/dL</td><td>&gt;7 criteria—100%</td></tr><tr><td>WBC &gt;16,000</td><td>Fluid sequestration &gt;6 L</td><td></td></tr></table>
======================================
<table><thead><th></th><th>Duodenal Ulcers</th><th>Gastric Ulcers</th></thead><tr><td>Pathogenesis</td><td>Caused by an increase in offensive factors (higher rates of basal and stimulated gastric acid secretion)</td><td>Caused by a decrease in defensive factors (gastric acid level is normal/low unless ulcer is pyloric or prepyloric)</td></tr><tr><td>Helicobacter pylori infection</td><td>70-90% of patients</td><td>60-70% of patients</td></tr><tr><td>Malignant potential</td><td>Low</td><td>High (5—10% are malignant)—should undergo biopsy to rule out malignancy</td></tr><tr><td rowspan="4">Location</td><td>Majority are 1—2 cm distal to pylorus and on posterior wall</td><td>Type I (most common, 70%): on lesser curvature</td></tr><tr><td></td><td></td><td>Type II: gastric and duodenal ulcer</td></tr><tr><td></td><td></td><td>Type III: prepyloric (within 2 cm of pylorus)</td></tr><tr><td></td><td></td><td>Type IV: near esophagogastric junction</td></tr><tr><td>Age distribution</td><td>Occurs in younger patients (&lt;40)</td><td>Occurs in older patients (&gt;40)</td></tr><tr><td>Associated blood type</td><td>Type O</td><td>Type A</td></tr><tr><td>Risk factors</td><td>NSAIDs</td><td>Smoking</td></tr><tr><td rowspan="2">Other</td><td>Eating usually relieves pain</td><td>Eating does not usually relieve pain</td></tr><tr><td></td><td>Nocturnal pain is more common than in gastric ulcers</td><td>Complication rates are higher than those of duodenal ulcers. There is a higher recurrence rate with medical therapy alone</td></tr></table>
======================================
<table><thead><th rowspan="2">TABLE 3-8,</th><th colspan="2">Crohn Disease Versus Ulcerative Colitis</th></thead><thead><th></th><th>Crohn Disease</th><th>Ulcerative Colitis</th></thead><tr><td rowspan="2">Involvement</td><td>Transmural—intestinal wall from mucosa to serosa</td><td>Mucosa and submucosa</td></tr><tr><td></td><td>Discontinuous involvement (skip lesions)</td><td>Continuous involvement (no skip lesions)</td></tr><tr><td rowspan="2">Location</td><td>Terminal ileum (most common)</td><td>Confined to colon and rectum</td></tr><tr><td></td><td>Can involve any part of the GI tract (resection is not curative—recurrences occur)</td><td>| Colectomy is curative</td></tr><tr><td>Complications</td><td>Fistulae and abscesses are more common than in UC because the entire wall is involved</td><td>SC and colorectal cancer are more common than in Crohn disease</td></tr></table>
======================================
<table><thead><th></th><th>Typel</th><th>Type II</th></thead><tr><td>Onset</td><td>Sudden</td><td>Gradual</td></tr><tr><td>Age at Onset</td><td>Any age (typically young)</td><td>Mostly in adults</td></tr><tr><td>Body Habitus _</td><td>Usually thin</td><td>Frequently obese</td></tr><tr><td>Ketosis</td><td>Common</td><td>Rare</td></tr><tr><td>Autoantibodies</td><td>Present in most cases</td><td>Absent</td></tr><tr><td>Endogenous Insulin</td><td>Low or absent</td><td>Can be normal, decreased, or increased</td></tr><tr><td>HLA Association</td><td>Yes (HLA-DQ/DR)</td><td>No</td></tr><tr><td>Genetic Factors</td><td>Concordance rate between identical twins is 50%.</td><td>Concordance rate between identical twins is 90%. Therefore, type II demonstrates a much stronger genetic component than type I.</td></tr></table>
======================================
<table><thead><th>Glucose Test</th><th>Impaired Glucose Tolerance (mg/dL)</th><th>Diabetes Mellitus (mg/dL)</th></thead><tr><td>Random plasma</td><td></td><td>&gt;200 with diabetic symptoms</td></tr><tr><td>Fasting</td><td>110-126</td><td>&gt;126 on two occasions</td></tr><tr><td>2-hr postprandial</td><td>140-200</td><td>&gt;200 on two occasions</td></tr><tr><td>Hemoglobin Alc (%)</td><td>5.7-6.4</td><td>&gt;6.5</td></tr></table>
======================================
<table><tr><td>Polydipsia</td><td>A physiologic response to diuresis to maintain plasma volume</td></tr><tr><td>Fatigue</td><td>Mechanism unknown, but probably due to increased glucose in plasma</td></tr><tr><td>Weight loss</td><td>Due to loss of anabolic effects of insulin</td></tr><tr><td>3lurred vision</td><td>Swelling of lens due to osmosis (caused by increased glucose)</td></tr><tr><td>“ungal infections</td><td>Fungal infections of mouth and vagina common—Candida albicans thrives under increased glucose conditions</td></tr><tr><td>Numbness, tingling of 1ands and feet</td><td>Neuropathy Mononeuropathy: due to microscopic vasculitis leading to axonal ischemia Polyneuropathy: etiology is probably multifactorial</td></tr></table>
======================================
<table><thead><th>Nonketotic</th><th>Syndrome</th><th></th></thead><tr><td></td><td>DKA</td><td>HHNS</td></tr><tr><td>Pathophysiology</td><td>Insulin deficiency — ketosis, acidosis, dehydration</td><td>Insulin deficiency — hyperosmolarity, osmotic diuresis, profound dehydration</td></tr><tr><td>Laboratory Findings</td><td>¢ Hyperglycemia (&gt;450) e Metabolic acidosis (anion gap)— serum pH &lt;7.3 ¢ Ketosis</td><td>¢ Hyperglycemia (&gt;900 mg/dL) «© Hyperosmolarity (&gt;320 mOsm/L) e Serum pH &gt;7.3 (no acidosis)</td></tr><tr><td>Treatment</td><td>Insulin, IV fluids, potassium</td><td>Aggressive IV fluids, low-dose insulin infusion</td></tr><tr><td>Mortality Rate</td><td>5-10%</td><td>10-20%</td></tr></table>
======================================
<table><thead><th>‘TABLE 48 Response to</th><th>the Water Deprivation Test</th><th></th></thead><thead><th></th><th>Increase in Urine Osmolality Above 280 mOsm/kg With Dehydration</th><th>Further Response to ADH</th></thead><tr><td>Normal patients</td><td>+</td><td></td></tr><tr><td>Diabetes insipidus patients</td><td></td><td></td></tr><tr><td>Nephrogenic diabetes insipidus patients</td><td></td><td></td></tr></table>
======================================
<table><thead><th>TABLE 4-9 Response to</th><th>Diagnostic Tests in Cushing Syndrome</th></thead><tr><td>Healthy patient</td><td>Normal cortisol/normal ACTH Suppression with low-dose dexamethasone Suppression with high-dose dexamethasone Mild increase with CRH test</td></tr><tr><td>Cushing disease</td><td>High cortisol/high ACTH No suppression with low-dose dexamethasone Suppression with high-dose dexamethasone Great increase in cortisol with CRH test</td></tr><tr><td>Adrenal tumor</td><td>High cortisol/low ACTH No suppression with low-dose dexamethasone No suppression with high-dose dexamethasone No change after CRH test</td></tr><tr><td>Ectopic ACTH-producing tumor</td><td>High cortisol/high ACTH No suppression with low-dose dexamethasone No suppression with high-dose dexamethasone No change after CRH test</td></tr></table>
======================================
<table><thead><th>TABLE 5-3</th><th>Delirium Versus Dementia</th><th></th></thead><thead><th>Feature</th><th>Delirium</th><th>Dementia</th></thead><tr><td>Causes</td><td>e Infections (UTI, systemic infection) e Medications (narcotics, benzodiazepines) ¢ Postoperative delirium (in elderly patients) e Alcoholism e Electrolyte imbalances e Medical conditions (stroke, heart disease, seizures, hepatic and renal disorders)</td><td>e Alzheimer disease e Multi-infarct dementia e Pick disease (Frontotemporal dementia)</td></tr><tr><td>Level of Consciousness</td><td>Altered, fluctuating</td><td>Preserved</td></tr><tr><td>Hallucinations</td><td>Frequently present (visual)</td><td>Rarely present</td></tr><tr><td>Presence of Tremor</td><td>Sometimes present (e.g., asterixis)</td><td>Usually absent unless dementia is due to Parkinson disease</td></tr><tr><td>Course</td><td>e “Sundowning” (worsening at night) may be present Rapid onset, waxing and waning</td><td>Insidious, progressive</td></tr><tr><td>Reversibility</td><td>Almost always reversible</td><td>Typically irreversible</td></tr></table>
======================================
<table><thead><th>TABLE 5-4) Glasgow Coma Scale</th><th></th><th></th></thead><tr><td></td><td>Opens spontaneously</td><td>| RWNE</td></tr><tr><td>Motor Response (M)</td><td>No movement</td><td></td></tr><tr><td></td><td>Decerebrate posture</td><td></td></tr><tr><td></td><td>Decorticate posture</td><td></td></tr><tr><td></td><td>Withdraws from pain</td><td></td></tr><tr><td></td><td>Localizes pain stimulus</td><td></td></tr><tr><td></td><td>Obeys commands</td><td></td></tr><tr><td rowspan="2">Verbal Response (V)</td><td>No sounds</td><td></td></tr><tr><td></td><td>Incomprehensible sounds Inappropriate words Appropriate but confused Appropriate and oriented</td><td>OBWNHRrFPIDUBPWNHeR</td></tr></table>
======================================
<table><thead><th>TABLE 5-5) Central Versus Peripheral</th><th>Vertigo</th></thead><tr><td>Central Vertigo</td><td>Peripheral Vertigo</td></tr><tr><td>Gradual onset</td><td>Sudden onset</td></tr><tr><td>Mild intensity</td><td>Severe intensity</td></tr><tr><td>Mild nausea/vomiting</td><td>Intense nausea/vomiting</td></tr><tr><td>Associated neurologic findings typically present</td><td>No associated neurologic findings</td></tr><tr><td>Mild nystagmus</td><td>Relatively intense nystagmus</td></tr><tr><td>Position change has mild effect</td><td>Position change has intense effect</td></tr><tr><td>No refractoriness—can repeat the “tilt” test and patient responds every time</td><td>Rapidly refractory—cannot repeat the “tilt” test; patient will not respond again</td></tr><tr><td>Patient falls to same side as lesion</td><td>Patient falls to same side as lesion</td></tr></table>
======================================
<table><tr><td>Direction of nystagmus:</td><td>multidirectional and even</td><td>Direction of</td><td>nystagmus:</td><td>unilateral vertical; nystagmus is</td></tr><tr><td>vertical</td><td></td><td>never</td><td>peripheral</td><td></td></tr></table>
======================================
<table><thead><th>Laboratory Marker</th><th>Conditions</th><th>Comments</th></thead><tr><td>ANAs</td><td>e SLE (almost all patients) ¢ Scleroderma e Sjogren syndrome ¢ Polymyositis</td><td>Highly sensitive for SLE but not for the others</td></tr><tr><td>RF</td><td>¢ RA(70% of patients) e Healthy populations (up to 3%)</td><td>Neither sensitive nor specific for RA</td></tr><tr><td>C-ANCA</td><td>GPA</td><td>Sensitive and specific Can vary with disease activity</td></tr><tr><td>P-ANCA</td><td>Polyarteritis nodosa</td><td>70-80% sensitive for microscopic PAN Not specific</td></tr><tr><td>Lupus anticoagulant</td><td>Antiphospholipid syndrome</td><td></td></tr><tr><td>ESR</td><td>e Infection (acute or chronic) e Malignancy e Rheumatologic diseases e Miscellaneous (tissue necrosis, pregnancy)</td><td>¢ Low sensitivity and specificity e Major uses: Diagnose/rule out inflammatory process and monitor course of inflammatory conditions</td></tr><tr><td>C-reactive protein</td><td>e Inflammatory states and infection e Miscellaneous conditions (e.g., MI,</td><td>e Primarily used for infection—much more sensitiv and specific than ESR</td></tr></table>
======================================
<table><thead><th>Diffuse</th><th>Limited</th></thead><tr><td>Widespread skin involvement</td><td>Skin involvement limited to distal extremities (and face, neck)—sparing of the trunk</td></tr><tr><td>Rapid onset of symptoms (skin and other complications occur rapidly after onset of Raynaud phenomenon)</td><td>Delayed onset: Skin involvement occurs slowly after the onset of Raynaud phenomenon</td></tr><tr><td>Significant visceral involvement (i.e., fibrosis of internal organs)—lung, heart, GI tract, kidneys</td><td>Visceral involvement occurs late—pulmonary HTN and ischemic vascular disease; minimal constitutional symptoms</td></tr><tr><td></td><td></td></tr><tr><td>Antitopoisomerase I (antiscleroderma-70) antibody</td><td>Anticentromere antibody</td></tr><tr><td>Poorer prognosis—10-yr survival is 40-65% e Peripheral edema (of hands and legs), polyarthritis, fatigue and weakness (muscle involvement), carpal tunnel syndrome e Renal failure can occur, but now rare</td><td>Better prognosis than diffuse form. Normal life span is expected in most cases, unless severe pulmonary HTN develops. CREST syndrome is a variant Calcinosis of the digits Raynaud phenomenon</td></tr></table>
======================================
<table><thead><th>TABLE 6-4</th><th>Extra-articular Manifestations in Rheumatoid Arthritis</th></thead><tr><td>Constitutional Symptoms</td><td>Malaise, Anorexia, Some Weight Loss, Fever</td></tr><tr><td>Cutaneous</td><td>e Skin becomes thin and atrophic and bruises easily e Vasculitic changes/ulcerations involving fingers, nail folds e Subcutaneous rheumatoid nodules (elbows, sacrum, occiput)—pathognomonic for RA</td></tr><tr><td>Pulmonary</td><td>Pleural effusions (very common)—pleural fluid characteristically has very low glucose and low complement Pulmonary fibrosis—with a restrictive pattern on pulmonary function tests and a honeycomb pattern on CXR e Pulmonary infiltrates Rheumatic nodules in lungs (similar to those on skin)}—can cavitate or become infected</td></tr><tr><td>Cardiac Eyes</td><td>Rheumatic nodules in heart—can lead to conduction disturbances (heart block and bundle branch block) Pericarditis—in 40% of patients with RA e Pericardial effusion © Scleritis</td></tr><tr><td>Nervous System</td><td>¢ Scleromalacia—softening of the sclera; if not treated may perforate, leading to blindness Dry eyes (and dry mucous membranes in general); may develop Sjogren syndrome Mononeuritis multiplex—infarction of nerve trunk. Implies systemic vasculitis, which</td></tr><tr><td>Felty Syndrome</td><td>is a bad sign Triad of RA, neutropenia, and splenomegaly</td></tr></table>
======================================
<table><thead><th>TABLE 6-7, Causes of Joint Pain</th><th></th></thead><tr><td>Polyarticular Joint Pain</td><td>Monoarticular Joint Pain</td></tr><tr><td>RA</td><td>Osteoarthritis</td></tr><tr><td>SLE</td><td>Gout</td></tr><tr><td>Viral arthritis</td><td>Pseudogout</td></tr><tr><td>Reiter syndrome</td><td>Trauma</td></tr><tr><td>Rheumatic fever</td><td>Septic arthritis</td></tr><tr><td>Lyme disease</td><td>Hemarthrosis</td></tr><tr><td colspan="2">Gonococcal arthritis</td></tr><tr><td>Drug-induced arthritis</td><td></td></tr></table>
======================================
<table><thead><th>Urine Osmolality</th><th>&gt;500 mOsm</th><th>250-300 mOsm</th></thead><tr><td>Urine Sodium</td><td>&lt;20</td><td>&gt;40</td></tr></table>
======================================
<table><tr><td>Prerenal Failure</td><td>Versus ATN</td><td></td></tr><tr><td></td><td>Prerenal Failure</td><td>| ATN</td></tr><tr><td>Urine osmolarity</td><td>| &gt;500</td><td>&gt;350</td></tr><tr><td>Urine Na®</td><td>&lt;20</td><td>&gt;40</td></tr><tr><td>FENa</td><td>&lt;1%</td><td>&gt;1%</td></tr><tr><td>Urine sediment</td><td>Scant</td><td>Full brownish pigment, granular casts with epithelial casts</td></tr></table>
======================================
<table><tr><td colspan="2">TABLE 7-4 Differentiation of AKI Versus CKD</td></tr><tr><td>Favors Chronic</td><td>Favors Acute</td></tr><tr><td colspan="2">History of kidney disease, HTN, abnormal urinalysis, edema —</td></tr><tr><td colspan="2">Small kidney size on renal ultrasound =</td></tr><tr><td>_—</td><td>Return of renal function to normal with time</td></tr><tr><td>Hyperkalemia, acidemia, hyperphosphatemia, anemia</td><td>Hyperkalemia, acidemia, hyperphosphatemia, anemia</td></tr><tr><td>—</td><td>Urine output &lt;500 mL/day without uremic symptoms</td></tr><tr><td>Urinalysis with broad casts (i.e., more than two to three WECs in diameter)</td><td>—</td></tr></table>
======================================
<table><thead><th>TABLE 7-5</th><th>Nephritic Versus Nephrotic</th><th>Syndrome</th></thead><tr><td></td><td>Nephritic Syndrome</td><td>Nephrotic Syndrome</td></tr><tr><td>Pathogenesis</td><td>Inflammation of glomeruli due to any of the causes of glomerulonephritis</td><td>| Abnormal glomerular permeability due to a number of conditions</td></tr><tr><td>Causes</td><td>Poststreptococcal glomerulonephritis is the most common cause, but may be due to any of the causes of glomerulonephritis</td><td>Many conditions. Membranous glomerulonephritis is the most common cause in adults. Other causes include diabetes, SLE, drugs, infection, glomerulonephritis (focal segmental and others) Minimal change disease is the most common cause in children</td></tr><tr><td>Laboratory Findings</td><td>Hematuria AKI—azotemia, oliguria Proteinuria, if present, is mild and not in nephrotic range</td><td>Urine protein excretion rate &gt;3.5 g/24 hr Hypoalbuminemia Hyperlipidemia, fatty casts in urine</td></tr><tr><td>Clinical Findings</td><td>HIN Edema</td><td>Edema Hypercoagulable state Increased risk of infection</td></tr></table>
======================================
<table><thead><th></th><th>Urine pH &gt;6 Nephrolithiasis and nephrocalcinosis do occur</th></thead><tr><td>2 (proximal)</td><td>Inability to reabsorb HCO; Increased bicarbonate excretion Nephrolithiasis and nephrocalcinosis do not occur</td></tr><tr><td>3 (mixed)</td><td>Rare autosomal recessive disorder: carbonic anhydrase II deficiency Characteristics of type I and II</td></tr><tr><td>4 (hyperaldosteronism)</td><td>Decreased Results in Nat absorption and H* and K* secretion in distal tubule hyperkalemia and acidic urine Nephrolithiasis and nephrocalcinosis are rare</td></tr></table>
======================================
<table><thead><th>‘TABLE 9-2</th><th>Severity of Thrombocytopenia and Associated Risk</th></thead><tr><td>Platelet Count</td><td>Risk</td></tr><tr><td>&gt;100,000</td><td>Abnormal bleeding (even after trauma or surgery) is unusual</td></tr><tr><td>20,000—70,000</td><td>Increased bleeding hemorrhage during surgery or trauma</td></tr><tr><td>&lt;20,000</td><td>Minor spontaneous bleeding: easy bruising, petechiae, epistaxis, menorrhagia, bleeding gums</td></tr><tr><td>&lt;5,000</td><td>Major spontaneous bleeding: intracranial bleeding, heavy GI bleeding</td></tr></table>
======================================
<table><tr><td>TABLE 9-3)</td><td>VWF Versus Factor VIII Coagulant Protein vWF (Also Known as Factor VIII-Related Antigenic Protein)</td><td>Factor VII Coagulant Protein</td></tr><tr><td>site of synthesis</td><td>Endothelial cells and megakaryocytes</td><td>Liver</td></tr><tr><td>‘unctions</td><td>Platelet adhesion—mediates the adhesion of platelets to the injured vessel walls (ie., it reacts with platelet GPIb/IX and subendothelium) e Binds the factor VIII coagulant protein and protects it from degradation</td><td>__—‘Fibrin clot formation</td></tr><tr><td>nheritance Pattern</td><td>Autosomal dominant</td><td>X-linked recessive</td></tr><tr><td>7WD</td><td>Low</td><td>Reduced</td></tr><tr><td>Temophilia</td><td>Normal</td><td>Very low</td></tr></table>
======================================
<table><thead><th>‘TABLE 9-5.</th><th colspan="4">Laboratory Findings for Bleeding Disorders</th></thead><thead><th>Condition</th><th>Platelet Count</th><th>Bleeding Time</th><th>PT</th><th>PTT</th></thead><tr><td>Hemophilia</td><td>NL?</td><td>NL</td><td>NL</td><td>Increased</td></tr></table>
======================================
<table><thead><th>vWD</th><th>NL</th><th>Increased</th><th>NL</th><th>Increased</th></thead><tr><td>ITP</td><td>Decreased</td><td>Increased</td><td>NL</td><td>NL</td></tr><tr><td>TTP</td><td>Decreased</td><td>Increased</td><td>NL</td><td>NL</td></tr><tr><td>DIC</td><td>Decreased</td><td>Increased</td><td>Increased</td><td>Increased</td></tr><tr><td>Heparin</td><td>NL or decreased</td><td>NL</td><td>NL</td><td>Increased</td></tr><tr><td>Warfarin</td><td>NL</td><td>NL</td><td>Increased</td><td>NL</td></tr><tr><td>Liver disease</td><td>NL</td><td>NL</td><td>Increased</td><td>Increased</td></tr></table>
======================================
<table><thead><th>Grade®</th><th>Type</th><th>Key Features</th><th>Prognosis</th></thead><tr><td>Indolent or — Low Grade _</td><td>Small lymphocytic lymphoma</td><td>© Closely related to CLL; more common in elderly patients e Indolent course</td><td>e Eventually results in widespread lymph node involvement with dissemination to liver, spleen, and bone marrow</td></tr><tr><td></td><td>Follicular, predominantly small, cleaved- cell lymphoma</td><td>e¢ Most common form of NHL Mean age of onset is 55 « May transform into diffuse, large cell; associated with translocation: t(14;18) e Indolent course e Presents with painless, peripheral lymphadenopathy</td><td>e Most patients with localized disease can be cured with radiotherapy, but only 15% of patients do have localized disease e Median survival is approximately 10 yrs</td></tr><tr><td>Intermediate</td><td>Diffuse, large- celllymphoma</td><td>¢ Predominantly B-cell origin e Middle-aged and elderly patients ¢ Locally invasive; presents as large extranodal mass</td><td>© 85% cure rate with CHOP therapy</td></tr><tr><td>High Grade</td><td>Lymphoblastic lymphoma</td><td>« T-cell lymphoma; more common in children « 50% of patients have B symptoms May progress to T-ALL</td><td>Aggressive with rapid dissemination, but may respond to combination chemotherapy</td></tr><tr><td></td><td>Burkitt (small noncleaved- cell) lymphoma</td><td>B-cell lymphoma; more common in children Two types: African and American; the African variety involves facial bone and jaw, whereas the American variety often involves</td><td>Grave prognosis unless treated very aggressively with chemotherapy Treatment may cure 50—</td></tr></table>
======================================
<table><thead><th></th><th></th><th>abdominal organs (hepatomegaly, abdominal masses, lymphadenopathy) African variety linked with EBV infection Associated with specific translocation: t(8;14)</th><th>60% of patients</th></thead><tr><td></td><td>Sézary syndrome</td><td>Involves skin as well as blood stream</td><td></td></tr><tr><td></td><td>HIV- associated lymphomas</td><td>Not a discrete entity: usually Burkitt or diffuse, large-cell lymphoma</td><td>* Very poor prognosis</td></tr></table>
======================================
<table><thead><th></th><th>Normal</th><th>Bacterial Meningitis</th><th>Aseptic Meningitis</th></thead><tr><td>WBC count (cells/mm?)</td><td>&lt;5</td><td>&gt;1,000 (1,000- 20,000)</td><td>&lt;1,000</td></tr><tr><td>WBC differential</td><td>All lymphocytes or monocytes; no PMNs</td><td>= Mostly PMNs</td><td>Mostly lymphocytes and monocytes</td></tr><tr><td>Glucose (mg/dL)</td><td>= 50-75</td><td>Low</td><td>Normal</td></tr><tr><td>Protein (mg/dL)</td><td>&lt;60</td><td>High</td><td>Moderate elevation</td></tr></table>
======================================
<table><thead><th>Age or Risk Factor</th><th>Likely Etiology</th><th>Empiric Treatment</th></thead><tr><td>Infants (&lt;3 mo)</td><td>Group B streptococci, E. coli, Klebsiella spp., L. monocytogenes</td><td>Cefotaxime + ampicillin + vancomycin (aminoglycoside if &lt;: weeks)</td></tr><tr><td>3 mo-5O yrs</td><td>N. meningitidis, S. pneumoniae, H. influenzae</td><td>Ceftriaxone or cefotaxime + vancomycin</td></tr><tr><td>&gt;50 yrs</td><td>S. pneumoniae, N. meningitidis, L. monocytogenes, Gram-negative bacilli</td><td>Ceftriaxone or cefotaxime + vancomycin + ampicillin</td></tr><tr><td>Impaired cellular immunity (e.g., HIV)</td><td>S. pneumoniae, N. meningitidis, L. monocytogenes, aerobic gram-negative bacilli (including P. aeruginosa)</td><td>Ceftazidime + ampicillin + vancomycin</td></tr></table>
======================================
<table><thead><th>System</th><th>Condition</th><th>Comments</th></thead><tr><td></td><td>pneumonia</td><td></td></tr></table>
======================================
<table><thead><th></th><th>infections)</th><th>¢ CMV or MAC: increased risk when the CD4 count &lt;50 C. neoformans, Histoplasma capsulatum, neoplasms (Kaposi sarcoma)</th></thead><tr><td rowspan="5">Nervous system</td><td>HIV-associated dementia</td><td>Progressive process in 33% of patients ¢ Occurs primarily in untreated patients with advanced HIV e Characterized by deficits in memory, executive functioning, attention, and concentration; apathy; and psychomotor slowing</td></tr><tr><td></td><td>Toxoplasmosis</td><td>Usually a reactivation of latent infection of Toxoplasma gondii « Symptoms both of a mass lesion (discrete deficits, headache) and of encephalitis (fever, altered mental status) ¢ CT scan or MRI shows characteristic findings: multiple (more than three) contrast-enhanced mass lesions in the basal ganglia and subcortical white matter though single lesions are possible</td></tr><tr><td></td><td>Cryptococcal meningitis</td><td>—_e _Diagnosed by identifying organisms in CSF by cryptococcal antigen, culture, or staining with India ink ¢ Treat with amphotericin B for 10-14 days. Follow this with 8-10 wks of oral fluconazole. Lifelong maintenance therapy with fluconazole is indicated</td></tr><tr><td></td><td>Other CNS infections</td><td>Bacterial meningitis, histoplasmosis, CMV, progressive multifocal leukoencephalopathy (PML), HSV, neurosyphilis, TB</td></tr><tr><td></td><td>Noninfectious CNS diseases</td><td>CNS lymphoma, CVA, metabolic encephalopathies</td></tr><tr><td rowspan="4">Gastrointestinal</td><td></td><td>Diarrhea</td><td>Most common GI complaint; caused by a variety of pathogens (E. coli, Shigella, Salmonella, Campylobacter, CMV, Giardia, Cryptosporidium, Isospora belli, Mycobacterium avium-intracellulare). Antibiotic therapy is also a common cause</td></tr><tr><td></td><td>Oral lesions</td><td>Oral thrush (candidiasis; scrapable), HSV or CMV (ulcers), oral hairy leukoplakia (EBV infection; nonscrapable), Kaposi sarcoma</td></tr><tr><td>Esophageal involvement</td><td>Candidiasis is most common cause of dysphagia; also CMV and HSV—seen with CD4 counts &lt;100</td></tr><tr><td></td><td>Anorectal disease</td><td>Proctitis—N. gonorrhoeae, C. trachomatis, syphilis, HSV</td></tr><tr><td>Dermatologic</td><td>Kaposi sarcoma</td><td>¢ More common in men who have sex with men than in other groups e Painless, raised brown-black or purple papules (common sites: face, chest, genitals, oral cavity) e Widespread dissemination can occur</td></tr></table>
======================================
<table><thead><th></th><th></th><th>and many other skin conditions/infections occur with higher frequency</th></thead><tr><td rowspan="4">Miscellaneous</td><td>CMV infection Mycobacterium</td><td>Common cause of serious opportunistic viral disease e Disseminated disease is common and usually involves the GI or pulmonary systems ¢ Most important manifestation is retinitis—unilateral visual loss that can become bilateral if untreated (seen in 5-10% of AIDS patients) * Colitis and esophagitis are other findings e Treat with ganciclovir or foscarnet</td></tr><tr><td></td><td>avium complex (MAC)</td><td>» Most common opportunistic bacterial infection in AIDS patients. Wasting syndrome (weight loss, fever), lymphadenopathy, anemia MAC causes disseminated disease in 50% of AIDS patients. MAC occurs in patients with advanced AIDS and fewer than 50 CD4 cells e Diarrhea and weight loss are constitutional symptoms</td></tr><tr><td></td><td>HIV-1 wasting syndrome</td><td>Profound involuntary loss of more than 10% of body weight in conjunction with either of the following: ¢ Chronic diarrhea (two or more stools per day for more than 1 mo) e Fever and persistent weakness for a similar period in the absence of another cause</td></tr><tr><td></td><td>Malignancies</td><td>e Kaposi sarcoma ¢ Non-Hodgkin lymphoma—rapidly growing mass lesion in CNS e Primary CNS lymphoma</td></tr></table>
======================================
<table><tr><td>TABLE 10-5</td><td>Antiretroviral Therapy</td><td></td></tr><tr><td>rug</td><td>Mechanism</td><td>Toxicity</td></tr><tr><td>Vucleoside Reverse \bacavir ABC) Jidanosine ddl)</td><td>Transcriptase Inhibitors (NRTIs) Competitively inhibit reverse transcriptase by lacking 3’ OH group. All are nucleosides and require phosphorylation to be active except tenofovir. ZDV used in pregnancy.</td><td>Mitochondrial toxicity (lactic acidosis), peripheral neuropathy (ddI, d4T), bone marrow suppression, megaloblastic anemia (ZDV), pancreatitis (ddI)</td></tr><tr><td>3TC) stavudine (d4T)</td><td></td><td></td></tr><tr><td>‘enofovir</td><td></td><td></td></tr><tr><td colspan="3">TDF) (only cleotide)</td></tr><tr><td colspan="3">alcitabine</td></tr><tr><td colspan="3">ddC)</td></tr><tr><td colspan="3">-idovudine</td></tr><tr><td colspan="3">ZDV, formerly</td></tr></table>
======================================
<table><thead><th>‘TABLE 10-7 Common</th><th>Pathogens in Cellulitis</th></thead><tr><td>Means of Bacterial Invasion</td><td>Likely Pathogen</td></tr><tr><td>Local trauma, breaks in skin</td><td>Group A Streptococcus (S. pyogenes)</td></tr><tr><td>Wounds, abscesses</td><td>S. aureus</td></tr><tr><td>Immersion in water</td><td>P. aeruginosa, Aeromonas hydrophila, Vibrio vulnificus</td></tr><tr><td>Acute sinusitis</td><td>H. influenzae</td></tr></table>
======================================
<table><thead><th>Adult (Relatively Healthy): Treat for S. aureus</th><th>Patient is Immunocompromised or has Significant Risk Factors for Gram- negative Arthritis</th><th>Young Adult With History and Presentation Consistent with Gonococcal Arthritis</th></thead><tr><td>Parenteral, B-lactamase— resistant penicillin (e.g., oxacillin) or first-generation cephalosporin x 4 wks</td><td>Parenteral, broad-spectrum antibiotics (with gram-negative coverage) (e.g., a third-generation cephalosporin or aminoglycoside) for 3-4 wks</td><td>Parenteral, third-generation cephalosporin (e.g., ceftriaxone) until there is improvement</td></tr><tr><td>Treat with vancomycin if MRSA is suspected</td><td>For pseudomonal infection, use aminoglycoside + extended-spectrum penicillin</td><td>Switch to an oral agent with gram- negative coverage (e.g., ciprofloxacin 3-10 days) once there</td></tr></table>
======================================
<table><thead><th>TABLE 10-13,</th><th>Common</th><th>Organisms in Various Infections</th></thead><tr><td>Pneumonia</td><td>Community- [AQ4]acquired Typical Atypical Nosocomial Aspiration pneumonia</td><td>S. pneumoniae, H. influenzae, Moraxella catarrhalis, Mycoplasma spp., Chlamydia spp., Legionella spp. S. aureus, gram-negative rods Oral anaerobes, gram-negative rods, S. aureus</td></tr><tr><td>Urinary Tract Infection</td><td></td><td>E. coli, S. saprophyticus, Enterococcus, Klebsiella, Proteus spp., Pseudomonas, Enterobacter, yeast (Candida spp.)</td></tr><tr><td rowspan="2">Osteomyelitis, Septic Arthritis</td><td></td><td>S. aureus, S. epidermidis, Streptococcus spp., gram-negative rods</td></tr><tr><td></td><td></td><td>Consider N. gonorrhoeae in septic arthritis in adolescents</td></tr><tr><td rowspan="2">Skin/soft Tissue</td><td>Surgical wound _</td><td>S. aureus, gram-negative rods</td></tr><tr><td></td><td>Diabetic ulcer</td><td>S. aureus, gram-negative rods, anaerobes</td></tr></table>
======================================
<table><thead><th></th><th>catheter site</th><th></th></thead><thead><th></th><th>Cellulitis</th><th>S. aureus, group A streptococci</th></thead><thead><th></th><th>Necrotizing fasciitis</th><th>C. perfringens, group A streptococci</th></thead><tr><td rowspan="4">Upper Respiratory</td><td>Pharyngitis</td><td>Viral, group A streptococci</td></tr><tr><td></td><td>Acute bronchitis</td><td>Viral</td></tr><tr><td></td><td>Acute sinusitis</td><td>Viral, S. pneumoniae, H. influenzae, M. catarrhalis</td></tr><tr><td></td><td>Chronic sinusitis</td><td>S. aureus, anaerobes</td></tr><tr><td rowspan="3">Endocarditis</td><td></td><td>Subacute</td><td>Streptococcus viridans</td></tr><tr><td>Acute</td><td>IV drug abuser: S. aureus, gram-negative rods, Enterococcus spp., yeast</td></tr><tr><td></td><td></td><td>Prosthetic valve: S. epidermidis</td></tr><tr><td>Gastroenteritis</td><td></td><td>Viral, Salmonella, Shigella, E. coli, C. botulinum, Giardia, Helicobacter spp., Campylobacter</td></tr><tr><td>Intra-abdominal</td><td></td><td>Enterococcus, Bacteroides fragilis, E. coli</td></tr><tr><td>Meningitis</td><td></td><td>See Table 10-3.</td></tr></table>
======================================
<table><thead><th>Rhinorrhea</th><th>|X</th><th></th></thead><tr><td>Myalgias</td><td>KM</td><td></td></tr><tr><td>Headache</td><td></td><td></td></tr><tr><td>Fever</td><td>x</td><td></td></tr><tr><td>Cough</td><td>x</td><td>x</td></tr><tr><td>Yellow sputum</td><td></td><td>x</td></tr></table>
======================================
<table><thead><th>Empty cane test</th><th>Technique: arms held out in front of the patient parallel to the ground with thumbs pointed downward. Resistance is applied by the examiner and the patient tries to maintain the position e Pain with resistance may indicate a supraspinatus defect</th></thead><tr><td>External rotation</td><td>e Technique: arm is held at patient’s side with elbow flexed at 90 degrees. Patient is asked to externally rotate the forearm against resistance. Pain with resistance may indicate an infraspinatus defect.</td></tr><tr><td>Lift-off test</td><td>Technique: patient’s hand is placed behind their back with the dorsum of the hand against the back. They are asked to lift their hand off their back. An inability to bring their hand off their back indicates a defect in internal rotation, which may indicate a subscapularis defect.</td></tr><tr><td>Neer test</td><td>Technique: the patient’s arm is fully pronated (thumb pointed downward) and forcibly flexed above their head. Pain with this maneuver may indicate rotator cuff impingement.</td></tr><tr><td>Hawkins test</td><td>Technique: patient’s arm is abducted to 90 degrees with the elbow bent (as if holding the arm out to catch a hawk), and the examiner internally rotates the shoulder. Pain with this maneuver may indicate rotator cuff impingement.</td></tr><tr><td>Cross-arm = test</td><td>e_ Technique: patient’s arm is held in front of them to 90 degrees and the patient actively adducts the arm (crosses it in front of them). e Pain at the acromioclavicular (AC) joint indicates AC joint dysfunction (which can be confused with rotator cuff pathology).</td></tr><tr><td colspan="2">Knee</td></tr><tr><td>Varus/valgus stress test</td><td>e Technique: examiner stabilizes the knee joint with one hand and uses the other hand to grab the lower leg and apply a lateral force. A varus stress is when the force on the knee is applied toward the body (in a lateral to medial), and a valgus stress is the opposite. Laxity with a varus stress implies a defect in the lateral collateral ligament (LCL), and laxity with a valgus stress implies a defect in the medial collateral ligament (MCL).</td></tr><tr><td>Lachman and anterior drawer</td><td>e Technique: the Lachman test is performed with the knee flexed at 30 degrees whereas the anterior drawer is performed with the knee flexed at 90 degrees. In both examinations, the proximal tibia is pulled anteriorly, away from the femur. e Excessive anterior translation of the tibia suggests an anterior cruciate ligament (ACL) tear.</td></tr><tr><td>Posterior drawer</td><td>e Technique: the patient is placed supine and the knee flexed at 90 degrees. The proximal tibia is pushed posteriorly toward the femur. e Excessive posterior translation of the tibia suggests a posterior cruciate ligament (PCL) tear.</td></tr><tr><td>McMurray test</td><td>‘Technique: the knee is passively flexed by the examiner, then externally rotated with a varus</td></tr></table>
======================================
<table><thead><th>‘TABLE 12-7, Bone</th><th>Mineral Density T-Score Criteria for Osteopenia and</th></thead><thead><th colspan="2">Osteoporosis</th></thead><tr><td>Diagnosis</td><td>T-Score</td></tr><tr><td>Normal</td><td>Greater than or equal to 1.0</td></tr><tr><td>Osteopenia</td><td>Between —1.0 and -2.5</td></tr><tr><td>Osteoporosis</td><td>Less than or equal to —2.5</td></tr><tr><td>Severe osteoporosis</td><td>Less than or equal to 2.5 and fragility fracture</td></tr><tr><td colspan="2">Adapted from World Health Organization, http://www.shef.ac.uk/FRA X/pdfs/WHO_Technical_Report.pdf</td></tr></table>
======================================
<table><thead><th>Upper Motor Neuron Signs</th><th>Lower Motor Neuron Signs</th></thead><tr><td>Spasticity</td><td>Flaccid paralysis</td></tr><tr><td>Increased deep tendon reflexes (hyperreflexia)</td><td>Decreased deep tendon reflexes</td></tr><tr><td>Babinski reflex (plantar response extensor)—toes upward (abnormal)</td><td>No Babinski reflex (plantar response flexor)—toe downward (normal)</td></tr><tr><td>No atrophy</td><td>Muscle atrophy</td></tr><tr><td>No fasciculations</td><td>Fasciculations present</td></tr></table>
======================================
<table><thead><th rowspan="2">Result of Test Under Investigation</th><th colspan="2">Result of Gold Standard</th></thead><thead><th></th><th>Disease Positive</th><th>Disease Negative</th></thead><tr><td>‘est positive (a 1 b)</td><td>True positive (a)</td><td>False positive (b)</td></tr><tr><td>‘est negative (c 1 d)</td><td>False negative (c)</td><td>True negative (d)</td></tr></table>